Healthcare News
Plasma exchange could expand treatment options for rare disease that threatens vision
Plasma exchange can help treat people with a rare inflammatory disease that can cause blindness, according to a systematic review and meta-analysis published in Neurology. Plasma exchange led to recovery for most people with the disease, which is called myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), and side effects were rare.
Source: Medical Xpress
FDA Approves First Treatment for Thyroid Eye Disease
The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED). Approval was granted to Viridian Therapeutics.
Source: Medical Xpress
Human study links reduced inflammation to later myopia onset
University of Oklahoma College of Medicine researcher Jody Summers, Ph.D., has long hypothesized that inflammation plays a role in the development of myopia, or nearsightedness, in which close-up vision is clear but distance vision is blurry. Her laboratory experiments have been convincing, and now she has preliminary human data to support the theory.
Source: Medical Xpress
Mind-wandering mechanisms change depending on eye state
A type of brain activity linked to arousal and attention can track mind wandering. But research conflicts on whether this activity promotes or hinders mind wandering. Esther Thielking of Barnard College and colleagues explored whether having the eyes open or closed changes the relationship between this brain activity and mind wandering.
Source: Medical Xpress
Low Dose Atropine Eye Drops Safe and Effective for Short-Sightedness in Children, Clinical Trial Suggests
Low-concentration atropine eye drops are a safe and effective treatment for short-sightedness (myopia) in UK children, although the effects are small, suggests a clinical trial published by The BMJ.
Source: Medical Xpress
